Cold atmospheric plasma (CAP) is a new therapy recently developed for cancer treatment. Studies have demonstrated that CAP is a very promising method for treatment different types of cancer in children and adolescents, including leukaemia (accounting for approximately 1 out of 3 cancers in children), osteosarcoma and neuroblastoma.
The highly reactive oxygen species (ROS) produced by plasma are thought to play a key role in entering cancer cells and responsible for apoptosis. Recent studies suggest that the reason why CAP treatment selectively affects cancer cells while leaving the healthy cells undamaged is the difference in lipid composition of cancer and healthy cell membranes the cancer cells are deficient of cholesterol.
Grant Award – Studentship 2018-2019
Funding Award – £1000
Funding Awarded to – Dr Anna Akinshina
Research Location – University of Salford
Lead Researcher – Dr Anna Akinshina
0161 295 3864 